Litcius/Paper detail

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19

Tarek Mohamed Abd El‐Aziz, Ahmed Al-Sabi, James D. Stockand

2020Signal Transduction and Targeted Therapy80 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRecombinant DNAPeptidyl-Dipeptidase ACoronavirus InfectionsBetacoronavirusVirologySars virusMedicineComputational biologyBiologyBiochemistryInternal medicineEnzymeInfectious disease (medical specialty)GeneDiseaseOutbreakEnzyme inhibitorAnesthesia and Neurotoxicity Research
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Litcius